I’ve been researching the cost structure and breakeven analysis based on gross margin and revenue. Current analyst consensus, while not extensive, even with the cost of debt included, suggests breakeven late 2025 / early 2026. if achieved, that is a “flying start”, and if adoption and growth is set to continue at even a modest relative to current, it stands to reason that 200m+ revenue could be achieved end of 26.
thoughts?
- Forums
- ASX - By Stock
- BOT - Anything but charting
BOT
botanix pharmaceuticals ltd
Add to My Watchlist
0.00%
!
29.5¢

I’ve been researching the cost structure and breakeven analysis...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $578.4M |
Open | High | Low | Value | Volume |
29.5¢ | 31.0¢ | 28.5¢ | $2.470M | 8.320M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 385171 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 385171 | 0.290 |
20 | 792931 | 0.285 |
27 | 405769 | 0.280 |
18 | 647997 | 0.275 |
15 | 1748850 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 100000 | 1 |
0.305 | 292233 | 6 |
0.310 | 302528 | 6 |
0.315 | 259523 | 3 |
0.320 | 116620 | 2 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
CDE
CODEIFAI LIMITED
John Houston / Martin Ross, Executive Chairman / COO
John Houston / Martin Ross
Executive Chairman / COO
Previous Video
Next Video
SPONSORED BY The Market Online